MYBPC2 and hypertrophic cardiomyopathy: Women with a MyBP‐C mutation have a later onset of disease but more frequent heart failure events compared to men, and women with hypertrophic cardiomyopathy are more likely to have sarcomere mutations (Lakdawala et al., 2021; Terauchi et al., 2015).